Harvard Bioscience Inc (HBIO) Reports Q3 2023 Earnings: Gross Margin Expands Amid Revenue Decline
Despite a 6% revenue decline, the company's gross margin improved significantly year-over-year
Stay updated with breaking news from Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite a 6% revenue decline, the company's gross margin improved significantly year-over-year
ZIVO Bioscience (NASDAQ:ZIVO – Get Free Report) and Krystal Biotech (NASDAQ:KRYS – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership. Earnings & Valuation This table compares ZIVO Bioscience […]
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Although U.S. stocks closed higher on Monday, there were a few notable insider trades.
Yield10 Bioscience and BioMar Group have signed an LOI to form a long-term partnership to commercialize a Camelina crop containing enriched levels of EPA and…